Abstract
Reports of neurological toxicity of cryopreserved stem cell infusion are infrequent. Three of 179 consecutive patients experienced significant neurological events in this context. Transient global amnesia developed following infusion in one patient and in the other two, cerebral infarction occurred. Profound hypotension, bradyarrhythmias or hypoxia were not associated with any of these episodes. These events may have been related to infused DMSO, which in the non-transplant setting has been associated with neurological toxicity and local infusion of which has resulted in acute vasospasm in animal models. These cases suggest that infusion of cryopreserved stem cells may result in cerebrovascular ischaemia. Bone Marrow Transplantation (2000) 25, 1285–1287.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alessandrino EP, Bernasconi P, Caldera D et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases Bone Marrow Transplant 1999 23: 533–537
Davis JM, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion Blood 1990 75: 781–786
Styler MJ, Topolsky DL, Crilley PA et al. Transient high grade heart block following autologous bone marrow infusion Bone Marrow Transplant 1992 10: 435–438
Ay H, Furie KL, Yamada K, Koroshetz WJ . Diffusion-weighted MRI characterizes the ischemic lesion in transient global amnesia Neurology 1998 51: 901–903
Hodges JR, Warlow CP . The aetiology of transient global amnesia. A case control of 114 cases with prospective follow-up Brain 1990 113: 639–657
Chaloupka JC, Huddle DC, Alderman J et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model Am J Neuroradiol 1999 20: 401–410
Yellowlees P, Greenfield C, McIntyre N . Dimethylsulphoxide-induced toxicity (letter) Lancet 1980 2: 1004–1006
Bond GR, Curry SC, Dahl DW . Dimethylsulphoxide-induced encephalopathy (letter) Lancet 1989 1: 1134–1135
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoyt, R., Szer, J. & Grigg, A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 25, 1285–1287 (2000). https://doi.org/10.1038/sj.bmt.1702443
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702443
Keywords
This article is cited by
-
A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells
Bone Marrow Transplantation (2021)
-
Cryopreservation in 95% serum with 5% DMSO maintains colony formation and chondrogenic abilities in human synovial mesenchymal stem cells
BMC Musculoskeletal Disorders (2019)
-
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
Nature Reviews Clinical Oncology (2019)
-
Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy
Bone Marrow Transplantation (2018)
-
Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact
Bone Marrow Transplantation (2018)